{"groups":[{"description":"Participants with solid tumors (other than metastatic melanoma or papillary thyroid cancer) or multiple myeloma who met the inclusion criteria and did not meet exclusion criteria of the study were enrolled and were evaluated for the presence of BRAF V600 mutations by collecting tumor samples or performing fresh biopsies according to local standards.","id":"FG000","title":"Participants With Confirmed Solid Tumors or Multiple Myeloma"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"114"}],"type":"No sampling or biopsy procedures done"}],"milestones":[{"achievements":[{"comment":"This includes all the participants who were enrolled for this study.","groupId":"FG000","numSubjects":"662"}],"type":"STARTED"},{"achievements":[{"comment":"This includes all the participants with mutation results from the sampling or biopsy procedures.","groupId":"FG000","numSubjects":"548"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"114"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}